Ovarian Cancer News

    November 2014

  • Diem Brown Has Lost Her Long Battle with Ovarian Cancer
    read more

  • October 2014

  • ASCO Calls for New Action to Address Obesity and Cancer
    read more

  • September 2014

  • Study of Jewish Women Shows Link to Cancer Without Family History
    read more

  • Dr. David Alberts to receive AACR Prevention Pioneer Award
    read more

  • Scientists create 'evolved' protein that may stop cancer from spreading
    read more

  • August 2014

  • Precision Therapeutics Supports the Annual National Ovarian Cancer Coalition (NOCC) Run/Walk to Break the Silence
    read more

  • July 2014

  • New Route For Ovarian Cancer Spread Uncovered By MD Anderson Researchers
    read more

  • Medical group urges against gynecological pelvic exams; other doctors disagree
    read more
    The National Ovarian Cancer Coalition (NOCC) supports yearly pelvic exams for women 21 years and older, as recommended by the American Congress of Obstetricians and Gynecologists (ACOG).

  • June 2014

  • Neoadjuvant Chemotherapy as Initial Treatment May Decrease Complications
    read more
    For more information, please visit the ASCO 2014 Annual Meeting web site.

  • Two Drug Combo Boosts Ovarian Cancer Survival
    read more
    For more information, please visit the ASCO 2014 Annual Meeting web site.

  • Gene Signature May Help Stratify Patients for Bevacizumab Therapy in High-Grade Serous Ovarian Cancer
    read more
    For more information, please visit the ASCO 2014 Annual Meeting web site.

  • May 2014

  • Valisia LeKae to Attend N. NA Chapter's 12th Annual Run/Walk This Sunday!
    read more

  • Broadway Star and Survivor, Valisia LeKae, Joins Forces with NOCC!
    read more

  • December 2013

  • Woman's Christmas Letters Reach Husband and New Family Two Years After Her Death
    read more

  • Research backs risk-reduction surgery for ovarian cancer
    read more

  • Advanced-stage ovarian cancer treated with targeted nanomedicine
    read more

  • Novel device able to monitor treatment response in ovarian cancer
    read more

  • The Next Front in Cancer Care
    read more

  • Genetic testing: A mother's advice, a daughter's decision
    read more

  • New test may help predict ovarian cancer survival
    read more

  • Drug delivery system successfully treats deadly ovarian cancer in mice
    read more

  • Study shows families don't understand genetic test results or their implications
    read more

  • November 2013

  • Stricken With Cancer, Baseball Diamonds Are This Girl's Best Friend
    read more

  • A literature review of the social and psychological needs of ovarian cancer survivors
    read more

  • Let cancer doctors innovate to help save more lives
    read more

  • Survivorship Care Plans, When Used, Promote Better, More Coordinated Care
    read more

  • Society of Gynecologic Oncology Releases List of Commonly Used Tests and Treatments to Question
    read more

  • October 2013

  • ASCO's 2013 Top Five List in Oncology
    read more

  • Understand the risks and benefits of ovary removal before menopause
    read more

  • IOM Report: Solving Cancer Care Crisis Starts With Improving Patient Engagement, Team-Based Care
    read more

  • Is Ovarian Cancer a Death Sentence?
    read more

  • University of Kentucky Highlights Importance Of Ovarian Cancer Screening
    read more

  • Doctors use heated chemo to treat ovarian cancer
    read more

  • Doctors dismissed me as grumpy teenager - in fact, I had ovarian cancer
    read more

  • New ovarian cancer treatment succeeds in the lab
    read more

  • Breaking Through Cancer's Shield
    read more

  • GP ovarian cancer testing soars by 200%, say researchers
    read more

  • Early Detection Means Positive Outcome Over Ovarian Cancer
    read more

  • Hereditary Breast and Ovarian Cancer: A Previvor's Perspective
    read more

  • UK - Ovarian Cancer Action call for policy change on genetic testing availability
    read more

  • September 2013

  • Breaking the Silence on Ovarian Cancer: Guyanna's Story
    read more

  • Women with recurrent ovarian cancer survive longer after treatment with cediranib
    read more

  • College-bound volunteers get double benefit
    read more

  • Why The Federal Government Wants To Redefine The Word 'Cancer'
    read more

  • Even health-conscious women get surprised by ovarian cancer
    read more

  • When the common symptoms are misinterpreted - Nancy's battle with Ovarian Cancer
    read more

  • Jacob Susskind, Maryland men's basketball team raise awareness for ovarian cancer
    read more

  • Paint the town teal for ovarian cancer awareness
    read more

  • Ovarian Cancer: Is There Anything You Can Do to Reduce Your Risk?
    read more

  • Tucson Giving: National Ovarian Cancer Coalition Tucson Chapter
    read more

  • Nashua ovarian cancer run/walk raises awareness
    read more

  • Fetterman: Family, friends support Dallas woman in battle with ovarian cancer
    read more

  • How cancer is like baseball - Meredith shares her journey as an Ovarian Cancer Survivor
    read more

  • Calling Out Ovarian Cancer
    read more

  • Team Becker Honors Courageous Leader at Cancer Fundraising
    read more

  • 15th Annual Break the Silence on Ovarian Cancer 5K
    read more

  • MB Real Estate kicks off Teal Lights campaign at headquarters office
    read more

  • Hearing the Whispers of Ovarian Cancer - Alice's Story
    read more

  • Lerner and Rowe Injury Attorneys Gives Back by Sponsoring the National Ovarian Cancer Coalitions (NOCC) Efforts to Increase Awareness and Survival Rates of Women
    read more

  • Local Woman Shares Her Story to Raise Awareness About Ovarian Cancer
    read more

  • Why Don't We Screen More Women for Ovarian Cancer?
    read more

  • Personalized Treatment For Ovarian Cancer Has Positive Results
    read more

  • 'Team Becker' rallies to raise funds, 'Break the Silence on Ovarian Cancer'
    read more

  • Teal Out
    read more

  • Nurse finds inspiration after cancer journe
    read more

  • Annapolis cancer survivor is educating the masses
    read more

  • August 2013

  • President Proclaims National Ovarian Cancer Awareness Month, 2013
    read more

  • Testing Strategy Aims To Find Ovarian Cancer In Early Stages
    read more

  • Wild Things to help raise ovarian cancer awareness
    read more

  • July 2013

  • New Research Helps Find Most Effective Chemo for Ovarian Cancer
    read more

  • June 2013

  • Justices rule human genes cannot be patented
    read more

  • ASCO Updates Fertility Preservation Guideline
    read more

  • ASCO: Discussing Fertility Preservation With Women
    read more

  • ASCO: Weekly Chemo Better in Ovarian Cancer
    read more

  • Drug shortages endanger cancer patients, study finds
    read more

  • Drug Used to Treat Kidney Cancer May Hold Off Relapses of Ovarian Cancer
    read more

  • May 2013

  • WHAT YOU DON'T KNOW MAY BE KILLING YOU
    read more

  • Olympic gymnast, health advocate, mother and cancer survivor Shannon Miller describes the balancing act of life.
    read more

  • U.K. to Pilot Illumina Genetic Test for Breast, Ovarian Cancer
    read more

  • Mixed reviews on removing fallopian tubes to prevent ovarian cancer
    read more

  • Cancers Share Gene Patterns, Studies Affirm
    read more

  • April 2013

  • Screening Detects Ovarian Cancer Using Neighboring Cells
    read more

  • One in Four Dissatisfied with Cancer Care Across the USA, Survey Shows
    read more

  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
    read more

  • AACR: Antibody-Drug Conjugate Shows Promise in Platinum-Resistant Ovarian Cancer
    read more

  • Ovarian cancer vaccine shows promise in trial
    read more

  • March 2013

  • Scientists ID genetic markers tied to breast, prostate, ovarian cancer; no quick payoff seen
    read more

  • Five genetic variations increase risk of ovarian cancer
    read more

  • Seeking Good News About Ovarian Cancer
    read more

  • Ovarian cancer patients getting substandard care?
    read more

  • Fertility After Ovarian Cancer
    read more

  • Shift Work Raises Ovarian Cancer Risk
    read more

  • Drug Duo Active in Pretreated Ovarian Cancer
    read more

  • 9 year-old child battles ovarian cancer
    read more

  • Widespread Flaws Found in Ovarian Cancer Treatment
    read more

  • Beta-Blockers Boost Survival in Ovarian Cancer
    read more

  • Abdominal 'Chemo Bath' May Extend Survival in Ovarian Cancer Patients
    read more

  • More Than 60 Percent of Ovarian Cancer Patients Do Not Receive Recommended Treatment
    read more

  • Intraperitoneal chemotherapy improved ovarian cancer survival
    read more

  • Spirituality May Boost Outcomes in Ovarian Cancer
    read more

  • Researchers Discover Origin of Aggressive Ovarian Cancer
    read more

  • Abdominal chemotherapy increases life by an extra three years on average
    read more

  • Screenings "Give False Reassurance" To Women Concerned About Ovarian Cancer
    read more

  • February 2013

  • Insight: Cancer drugs proving worth earlier in testing
    read more

  • Obesity and ovarian cancer may have only a small link
    read more

  • EHR use tied to more women's health tests: study
    read more

  • Cancer Rehab Begins To Bridge A Gap To Reach Patients
    read more

  • Drug to target hardest-to-kill cancer cells
    read more

  • No increased cancer risk after IVF: study
    read more

  • Novel test predicted presence of BRCA mutations
    read more

  • Nine-year-old ovarian cancer survivor shares her story
    read more

  • UACC-St. Joseph's researchers discover potentially groundbreaking ovarian cancer treatment
    read more

  • Penn study finds two-step immunotherapy attacks advanced ovarian cancer
    read more

  • January 2013

  • Study: High blood calcium levels may indicate ovarian cancer
    read more

  • All about the bed bath and beyond coupon
    read more

  • Results from Morphotek's farletuzumab Phase III combination study on ovarian cancer
    read more

  • How pap smears could detect ovarian, uterine cancer
    read more

  • Pap smears can detect ovarian and endometrial cancers, Hopkins scientists find
    read more

  • Help cancer survivors address extreme concerns following completion of treatment
    read more

  • December 2012

  • New Genetic Tests Determines Breast Cancer and Ovarian Cancer Risks
    read more

  • Ovarian cancer an under-the-radar killer
    read more

  • November 2012

  • Diabetes Drug Metformin May Fight Cancer
    read more

  • Some women overwhelmed by cancer treatment options
    read more

  • The dogs ruled the day at the National Ovarian Cancer Coalition Conference
    read more

  • Ovarian Cancer Patients Have Lower Mortality Rates When Treated at High-Volume Hospitals
    read more

  • October 2012

  • Acupuncture may help ease cancer-related fatigue: study
    read more

  • Genetic testing offers hope to cancer patients
    read more

  • Wayne State Gets $1M Gift For Ovarian Cancer Research
    read more

  • Janssen Products, LP restores full access to Doxil
    read more

  • Aspirin May Help Prevent Ovarian Cancer
    read more

  • Hormone Replacement Therapy May Cause 5 Percent of Ovarian Cancer
    read more

  • UK ovarian cancer survival 'lower'
    read more

  • September 2012

  • New Chemotherapy Strategy Emerges in Ovarian Cancer
    read more

  • Basal-like breast cancer similar to ovarian cancer
    read more

  • Gynecological Cancer: 5 Signs Women Ignore
    read more

  • Quick Questions Help ID Ovarian Cancer Risk
    read more

  • UA Cancer Center Leads Healthy Lifestyle, Ovarian Cancer Study
    read more

  • NOCC Teal Lights Celebration & Fundraiser Illuminating the Chicago Skyline Teal
    read more

  • Cancer Center leads healthy lifestyle study in ovarian cancer progression-free survival
    read more

  • Natalie Cosman, 8-Year-Old Diagnosed With Ovarian Cancer, Is Now Cancer-Free
    read more

  • Student Cancer Advocate at W&J Spreads Awareness Across Campus, Community
    read more

  • 8-year-old ovarian cancer survivor raises money and awareness
    read more

  • Cancer survival rates different for married and single women
    read more

  • Living With Ovarian Cancer; A Story of Survival
    read more

  • Girl, 8, survives ovarian cancer
    read more

  • The Case For and Against Ovarian Cancer Screenings
    read more

  • Kathy Bates Recovering from Double Mastectomy
    read more

  • New Ovarian Cancer Screening Guidelines Highlight Lack Of Options For Women
    read more

  • Ovarian cancer screenings not recommended as a routine
    read more

  • Ovarian cancer patient shares details of her journey to recovery
    read more

  • Tool To Predict Chemotherapy Side Effects
    read more

  • 7-Year-Old Wins Battle With Ovarian Cancer
    read more

  • August 2012

  • Today's Chicago Woman - Are you At Risk?
    read more

  • Presidential Proclamation - National Ovarian Cancer Awareness Month
    read more

  • Ovarian cancer: why don't we ever talk about it?
    read more

  • Court Reaffirms Right of Myriad Genetics to Patent Genes
    read more

  • Low vitamin D linked to high ovarian cancer death risk
    read more

  • Johnson and Johnson Provides Added Doxil Supply for Clinical Studies
    read more

  • July 2012

  • Vermillion ovarian cancer test shows positive result
    read more

  • June 2012

  • Caris Life Sciences Announces Upcoming Launch of Caris Target Now Select(TM)
    read more

  • Avastin May Help Fight Tough-to-Treat Ovarian Tumors
    read more

  • Genentech Study Showed That Adding Avastin to Chemotherapy Cut the Risk of the Disease Getting Worse in Difficult-to-Treat Recurrent Ovarian Cancer by Half
    read more

  • May 2012

  • Garden brings cancer sufferer hope
    read more

  • The stunning "henna crowns" helping cancer victims come to terms with their hair-loss
    read more

  • Women get less information on post-cancer fertility
    read more

  • Professor writes about painful effects of ovarian cancer
    read more

  • Esperance initiates enrollment in EP-100 and paclitaxel Phase 2 combination trial for ovarian cancer
    read more

  • Son Helps His Mother Fight Cancer With Healing Garden
    read more

  • Cancer survivor runs for awareness
    read more

  • Dogs Training to Sniff Out Ovarian Cancer
    read more

  • "Cancer that whispers" will take center stage at Pittsburgh symposium
    read more

  • Important Updates on DOXIL Supply Shortage
    read more

  • Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Cancer to FDA
    read more

  • Brasser Research Center to Focus on BRCA Cancer Genes
    read more

  • Fallopian tube removal may lower risk of deadly ovarian cancer
    read more

  • April 2012

  • Venus Remedies developing new cancer drug delivery technology
    read more

  • A way for you to save some money
    read more
    Getting treatment can be very expensive. One of the ways to manage your finances is to use coupons for great savings. Bed bath and beyond is one the largest retailers in the country and they offer a large assortement of coupons for their customers. Bedbathandbeyondsave.com is one of the places where you will get all the information you need about finding a bed bath and beyond coupon online. Visit them and check out what they have.

  • Add-on bevacizumab slows progression of recurrent ovarian cancer
    read more

  • Impact of Cancer Treatment on Memory, Thinking, and Attention
    read more

  • Important Updates on DOXIL® Supply Shortage
    read more

  • Why we need a good screening test for ovarian cancer
    read more

  • DNA Repair Genes May Predict Ovarian Cancer Survival
    read more

  • US Panel Says Women Shouldn't Get Ovarian Cancer Screening
    read more

  • Cancer Death Rates Drop Again
    read more

  • Taller, Heavier Women May Face Higher Ovarian Cancer Risk
    read more

  • March 2012

  • Black women, uninsured get worse ovarian cancer care: Study Says
    read more

  • Many young cancer patients don't discuss fertility
    read more

  • Minorities, young people take longer to diagnose for cancer, UK study says
    read more

  • Some pregnancies can continue despite cervical, ovarian cancers
    read more

  • February 2012

  • Endometriosis linked to Increased Risk of Certain Types of Ovarian Cancer
    read more

  • FDA Announces Replacement Drug for Doxil,on Short Supply, to be Imported
    read more

  • Ovarian cancer screening popular despite guidelines
    read more

  • December 2011

  • Studies Find Avastin Can Stabilize Tumors in Ovarian Cancer
    read more

  • EU Approves Avastin for Ovarian Cancer
    read more

  • New Funds Approved for Ovarian Cancer Research
    read more

  • Oophorectomy before age 45 could mean lower bone mineral density
    read more

  • Chemo Combo Kills Resistant Ovarian Cancer Cells
    read more

  • October 2011

  • Study Shows Ovarian Cancer May Be Tied To Fertility Treatments
    read more

  • Information on Doxil Shortage
    read more

  • September 2011

  • New Breakthrough For Ovarian Cancer Surgeries
    read more

  • NOCC hosts awareness luncheon with Shannon Miller
    read more

  • NOCC partners with The Dr. Oz Show for episode on ovarian cancer
    read more

  • Dr. Oz and NOCC provide fact sheet for women to bring to doctors
    read more

  • FDA Clears Biomarker Test For Women With Adnexal Ovarian Mass
    read more
    Fujirebio Diagnostics has recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company’s HE4 Test in an algorithm called ROMA™ (HE4 EIA + ARCHITECT CA 125 IITM)* to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

    The ROMA (Risk of Ovarian Malignancy Algorithm) test uses the results from simple blood tests, CA125 and HE4, to identify patients presenting with adnexal mass as high or low likelihood for finding malignancy on surgery. HE4 has been shown to be elevated in epithelial ovarian cancers (EOC), the most common type of ovarian cancer, but is not elevated in many benign gynecologic diseases. Combining physician assessment with the independently validated ROMA algorithm enables physicians to identify those patients at high likelihood of malignancy who should have their surgery performed by a gynecologic oncologist.

     “Using ROMA with HE4 and CA125 significantly improves our ability to identify women who are at high or low likelihood of having ovarian cancer when they present with an ovarian cyst or mass,” said Richard G. Moore, MD, Associate Professor of Obstetrics and Gynecology at the Alpert School of Medicine at Brown University and Director of the Center for Biomarkers and Emerging Technologies in the Program for Women’s Oncology at Women and Infants’ Hospital in Providence, RI. “Patients who have ovarian cancer have better outcomes when their surgery is performed by a gynecologic oncologist at centers experienced in the management of this disease. This combination test will allow physicians to identify those patients who should be treated by a gynecologic oncologist and equally important allow women with benign disease to stay in their communities with the physician who knows them best. It will change the way doctors diagnose and treat ovarian cancer,” added Dr. Moore, who is the lead researcher for the team that developed ROMA and author of two multi-center studies investigating the use of HE4 and CA125 and ROMA.

    Ovarian cancer is recognized as difficult to diagnose because its symptoms are easily confused with other non-cancerous conditions. Three quarters of cases of ovarian cancer are diagnosed at an advanced stage, when it is more difficult to treat. Of patients who are diagnosed early (Stage I-II), more than 90 percent will live past five years. However, only one quarter of cases are diagnosed in the early stages.

    “The clearance of ROMA is a major advance for the gynecologist and will become an important component of the preoperative assessment of women presenting with a pelvic mass,” said Lee P. Shulman, MD, Professor of Obstetrics and Gynecology, Chief of the Division of Clinical Genetics and Co-Director of the National Ovarian Cancer Early Detection Program at Northwestern University.

     

  • NOCC featured in Women Magazine
    read more

  • President Proclaims September National Ovarian Cancer Awareness Month
    read more

  • August 2011

  • Austin Chapter's Run/Walk Raises Awareness!
    read more

  • Dr. Oz joining the NOCC in Dallas on Saturday, August 20
    read more

  • NOCC volunteer shares her story with Health Magazine
    read more

  • Antibody that could detect early ovarian cancer detected
    read more

  • Scientists Pinpoint Ovarian Cancer Gene
    Is treatment on the way?
    read more

  • How To Protect Yourself From Ovarian Cancer
    read more

  • How You Can Take Action
    read more

  • June 2011

  • FDA Panel Opposes Avastin for Breast Cancer
    read more

  • Drug Shortages Leave Cancer Patients at Risk
    read more

  • DOXIL shortages to patients
    read more
    (FDA) and healthcare professionals of a potential supply interruption we are managing with Centocor Ortho Biotech Products, L.P. recently informed the US Food and Drug Administration

    DOXIL® 20-mg and 50-mg vials for injection that may result in shortages to patients over the next several weeks.

    It may take several weeks to restock the market and there may be intermittent back orders during this period. It’s important to note that the supply situation is not related to product quality or safety.

    Centocor Ortho Biotech Products, L.P is aware that patients rely on this product and are working to resupply the market as quickly as possible. During this time, treating physicians may need to make prescribing decisions based on individual patient circumstances. The Medical Information Center is available at 1-800-526-7736 for healthcare professionals who may have questions.

    Additional information about DOXIL® can be found at www.DOXIL.com.

  • May 2011

  • Prima Biomed Clinical Trials Offer Significant Upside
    read more

  • April 2011

  • Ovarian Cancer Starts Elsewhere, Study Says
    read more

  • Experimental drug slows ovarian cancer growth
    Survival increased in mouse model
    read more

  • Chemo Plus Avastin Shows Benefit in Ovarian Cancer
    read more

  • Ovarian Cancer Prognosis May Depend on Gene Mutations
    Women with BRCA2 had best survival rate in study
    read more

  • March 2011

  • Dr. Joel Fuhrman's Cancer-Prevention Diet
    read more

  • February 2011

  • Ovarian cancer symptoms: What you need to know
    read more

  • Lymph Node Biopsies Recommended
    read more

  • January 2011

  • Improved survival in non-Ashkenazi Jewish ovca patients with BRCA1 and BRCA2 gene mutations
    read more

  • December 2010

  • Study Pans Ovarian Cancer Screening Usefulness
    read more

  • NJ Store Raises Funds for Awareness
    read more

  • October 2010

  • Hikers Raise Awareness for Ovarian Cancer
    read more

  • Ovarian Cancer Featured on "The Dr. Oz Show"
    read more

  • Ovarian Cancer Frequently Misdiagnosed
    70% in NOCC Study Say Doctors Fail to Mention the Disease
    read more

  • September 2010

  • BEAT Campaign Spreads Awareness of Ovarian Cancer Symptoms
    read more

  • Optimizing Chemotherapy with Bevacizumab for Ovarian Cancer
    Information on Clinical Trial
    read more

  • Preventative Surgeries May Prevent Ovarian Cancer
    read more

  • August 2010

  • New Ovarian Cancer Test Shows Promise
    read more

  • July 2010

  • Genetic Marker Linked to Ovarian Cancer Risk
    read more

  • The Voice of a Survivor
    read more

  • Second Phase III Study Showed Avastin Slowed Ovarian Cancer Progression
    read more

  • June 2010

  • NOCC Raises Awareness at LPGA Championship
    read more

  • Bride's Wedding is a Cancer Survivor's Way of Helping the Cause
    read more

  • Positive Results From Phase 2 Clinical Study In Women with Platinum-Resistant Ovarian Cancer
    read more
    Nektar Therapeutics announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in women with platinum-resistant refractory ovarian cancer.   The response rate was higher than what would have been expected, and the median progression-free survival of eighteen weeks is longer than what would be expected in women with a median platinum-free interval of only one month.

    The NOCC believes that the preliminary data of this study is encouraging.  We will provide more results on further studies as they become available.

  • Debulking Predicts Survival in Recurrent Ovarian Cancer
    read more

  • Study: Avastin Slows Ovarian Cancer
    read more

  • Abbott Receives FDA Clearance for New Ovarian Cancer Test
    read more

  • May 2010

  • Allergy sufferers less likely to develop cancer, scientists say
    read more

  • Ovarian cancer screening shows promise
    Study: New approach finds deadly tumors without too many false alarms
    read more

  • Curcumin pretreatment helps destroy ovarian cancer cells
    read more

  • April 2010

  • Processed meat linked to higher ovarian cancer risk
    read more

  • High Stress Levels May Promote Ovarian Cancer
    read more

  • Screening Tool for Ovarian Cancer Identified
    Four-biomarker panel has 86 percent sensitivity, 98 percent specificity for stages I and II disease
    read more

  • Attacking Ignorance - Learn the Symptoms of Ovarian Cancer
    read more

  • March 2010

  • Aspirin, Other Pain Relievers Could Cut Risk Of Breast, Ovarian Cancer
    read more

  • NOCC Talks to Developer of New OVA1 Test
    read more

  • February 2010

  • Genentech Announces Positive Results of Avastin Phase III Study in Women... with Advanced Ovarian Cancer
    First Phase III study of an anti-angiogenic therapy in advanced ovarian cancer to meet primary endpoint
    read more

  • Regular Aspirin Use Lowers the Risk of Developing Ovarian Cancer
    read more

  • January 2010

  • Understand Your Risks for Ovarian Cancer
    read more

  • Pelvic Symptoms May Not Mean Ovarian Cancer
    read more

  • Combo Test Might Spot Ovarian Cancer Early
    read more

  • Combo Test Might Spot Ovarian Cancer Early
    read more

  • December 2009

  • Researchers make progress on early detection of ovarian cancer
    read more

  • Most Ashkenazi Jewish women should be tested for breast cancer genes, study finds
    read more

  • Arrayit Corporation Announces Manufacturing Breakthrough
    read more

  • Study Offers New Option for Women With Ovarian Cancer
    read more

  • Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
    read more

  • Possible Ovarian Cancer Treatment Target Identified
    read more

  • Diet Rich in Soy May Lower Risk of Ovarian Cancer
    read more

  • Report: US Cancer Cases, Deaths, Continue to Decline
    read more

  • OU Research Could Give Hope in Cancer Fight
    Compound is Being Tested That May Lead to Preventative Drug
    read more

  • November 2009

  • Pertuzumab plus Gemzar® Active in Platinum-resistant Ovarian Cancer
    read more

  • Ovarian cancer still lacks reliable early diagnostic test
    read more

  • Leukemia Drug May Help Some Ovarian Cancer Patients
    read more

  • U.S. Patent Office Issues Vermillion Patent for Biomarkers Detecting Ovarian Cancer
    read more

  • Nanoparticles for gene therapy improve
    read more

  • Court upholds right of scientists and patients to challenge gene patents
    read more

  • AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer
    read more

  • Zeltia gets final EU okay for Yondelis drug
    read more

  • October 2009

  • Ovarian Cancer Drug Tested In San Antonio
    read more

  • I Got Sick Then I Got Better
    Theatre Review
    read more

  • Partnership formed to detect ovarian cancer
    read more

  • Researchers say rare metals can aid in fighting colon, ovarian cancer
    read more

  • Color of hope: Teal ribbon shows support for women facing ovarian cancer
    read more

  • New Ovarian Cancer Test Can Hone Referrals
    read more

  • Walk In North Park Raises Ovarian Cancer Awareness
    read more

  • The fight of her life
    read more

  • The Enemy Within
    NorthShore Magazine
    read more

  • September 2009

  • The FDA Rejects Another Good Cancer Drug
    read more

  • Gene mutation is clue about cancer risks among Ashkenazi women
    read more

  • Modified Chemo Regimen Effective in Advanced Ovarian Cancer
    Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination, Japanese researchers reported last week.
    read more

  • UPDATE 1, Nektar cancer drug shows promise in early trial
    read more

  • Fertility Preservation Possible for Women with Ovarian Cancer
    read more

  • Ovarian cancer walk raises $35,000
    read more

  • Vermillion/Quest OVA1 Ovarian Cancer Risk Test Cleared by FDA
    read more

  • New Research May Aid Earlier Detection Of Ovarian Cancer
    read more

  • Get your bed bath and beyond coupons here
    read more
    Grab a coupon for bed bath and beyond at http://www.printablecouponsonline.net

  • New Treatment for Ovarian Cancer Looks Promising
    read more

  • Join walk for ovarian cancer awareness
    read more

  • Butterflies Released to Remember Ovarian Cancer Victims
    read more

  • Hope Comes with Grant to Fight Ovarian Cancer
    read more

  • August 2009

  • Suicide Genes Help Slow Ovarian Tumor Growth in Mice
    read more

  • Campaign For The Teal Ribbon
    read more

  • Toward Earlier Detection of Ovarian Cancer
    read more

  • Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk
    Women with BRCA gene mutations often choose preventive measures, study finds
    read more

  • CAU and Georgia Tech collaborate to fight cancer
    read more

  • July 2009

  • Abbott, Fujirebio Co-Developing HE4/CA125 Dx to Improve Early Ovarian Cancer Detection
    read more

  • Rare Ovarian Cancer Caused by One Genetic Mutation
    read more

  • Low Ovarian Cancer Detection Rate by Symptoms Alone
    Transvaginal ultrasound may be a more sensitive way to look for ovarian malignancy
    read more

  • Symptoms absent in 80% of ovarian cancer patients
    read more

  • Hormone Therapy Increases Odds of Ovarian Cancer
    But risk remains low and decreases two years after stopping, study finds
    read more

  • Menstrual Periods: Clues to Ovarian Cancer
    Study Shows Risk of Death From Ovarian Cancer Linked to Overall Number of Ovulatory Cycles
    read more

  • Does Race Affect Cancer Survival?
    Breast Cancer Deaths Higher for Black Women Despite Equal Treatment
    read more

  • June 2009

  • Platypus Link to Ovarian Cancer
    Researchers from the Royal Adelaide Hospital and University of Adelaide believe our oldest mammalian relative may help us to better understand ovarian cancer
    read more

  • Holy Grail Of Cancer Research?
    PARP Inhibitors May Ease Side Effects Of Chemotherapy
    read more

  • New Cancer Drug Fights Tumors in Those With BRCA Mutations
    Olaparib prevents malignant cells from repairing themselves, researchers say
    read more

  • Ovarian Cancer Breakthrough Heralds New Era of Treatment
    read more

  • Chickens are the only animals besides humans known to suffer from ovarian cancer
    read more

  • May 2009

  • Spare the Ovaries! What Women Should Ask Before a Hysterectomy
    read more

  • Brave schoolgirl, eight, becomes youngest Briton to battle ovarian cancer
    read more

  • Sharing Cancer Info May Be Empowering
    Telling children about genetic risks fosters openness, expert says
    read more

  • Early-Stage Ovarian Cancers Develop Less Aggressively
    read more

  • Screening Tests Missing Early Signs of Ovarian Cancer
    read more

  • Genetic Profile Found that Predicts Best Chemotherapy for Ovarian Cancers
    read more

  • April 2009

  • Addition Of Dasatinib To Standard Chemo Cocktail May Enhance Effect In Certain Ovarian Cancers
    read more
    ScienceDaily (Apr. 25, 2009) - The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.

  • Genetic Variations In MiRNA Processing Pathway And Binding Sites Help Predict Ovarian Cancer Risk
    read more
    ScienceDaily (Apr. 23, 2009) - Genetic variations in the micro-RNA (miRNA) processing pathway genes and miRNA binding sites predict a woman’s risk for developing ovarian cancer and her prospects for survival, researchers from The University of Texas M. D. Anderson Cancer Center reported at the 100th annual meeting of the American Association for Cancer Research.

  • Novogen's NV-128 Targets the MTOR Pathway to Block Differentiation And Induce Cell Death In Ovarian Cancer Stem Cells
    read more
    (Apr. 21, 2009) - Data presented at the Annual Meeting of the American Association for Cancer Research in Denver has demonstrated that NV-128, a Novogen, Limited (ASX: NRT) (NASDAQ: NVGN) synthetic isoflavonoid compound, not only induces cell death in Ovarian Cancer Stem Cells (OCSCs), but also blocks their differentiation into structures which are required to support tumor growth.

  • Lpathomab®, Compelling New Preclinical Results - Ovarian Cancer
    read more
    (Apr. 21, 2009) - Lpath, Inc. (OTCBB:LPTN), the category leader in bioactive-lipid-targeted therapeutics, reported compelling new in vivo and in vitro results relating to its preclinical drug candidate, Lpathomab, in various ovarian cancer studies. The results were presented today by Lpath scientists at the 100th Annual Meeting of the American Association for Cancer Research (AACR) in Denver, Colorado.

  • Hysterectomy: Spare Ovaries, Boost Health?
    Ovary Removal Decreases Ovarian Cancer Risk but Increases Risk of Heart Disease and Death, Study Says
    read more
    (Apr. 21, 2009) -- Ovary removal during a hysterectomy is often done to reduce the risk of ovarian cancer. But doing so also boosts the risk of heart disease and death long-term, according to a new study.

  • Gene variations could predict ovarian cancer risk
    Variations within women's genes could predict risk for ovarian cancer, a new study has found
    read more
    (Apr. 20, 2009) - Researchers at the University of Texas M.D. Anderson Cancer Center report that women who had eight or more of these unfavorable variations, or genotypes, were 4.5 times more likely to develop ovarian cancer, and women with six to eight of the genotypes were at twice the risk. The findings are being reported at the 100th annual meeting of the American Association for Cancer Research.

  • Researchers at Melbourne's Peter MacCallum Cancer Centre have discovered a genetic key that could lead to world-first cure for ovarian cancer.
    read more
    (Apr. 20, 2009) - A major Australain study is investigating whether gene mutations are responsible for the cancer, which claims the lives of 800 Australian women each year.

  • Chemo Combo Shows Promise Against Ovarian Cancer
    read more
    HealthDay News (Apr. 19, 2009) -- Adding the drug dasatinib to a standard, two-drug chemotherapy regimen for treating ovarian cancer boosted the effectiveness of the drugs in laboratory tests, new research shows.

  • Some Radiation Therapy Treatments Can Decrease Fertility
    read more
    ScienceDaily (Apr. 12, 2009) - In female cancer patients of reproductive age, radiation treatment directly to the ovaries should be avoided because there is a direct relationship between certain types of radiation therapy and fertility problems, according to a review in the April 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

  • A mother's last wish: To see daughter wed
    Volunteer organization helps cancer-stricken woman see dream wedding
    read more
    (Apr. 9, 2009) - It’s a video wedding album that doesn’t leave a dry eye in the house - a mother giving away her daughter at a ceremony she might never had attended, at a financial cost she could never hope to meet.

  • Ovarian Cancer Screening Resulted in Many Unnecessary Surgeries
    read more
    National Cancer Institute (Apr. 7, 2009) - Screening women for ovarian cancer often led to unnecessary surgeries and failed to detect the disease in its early stages, according to new results from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. The analysis focused on the 34,000 women in the NCI-sponsored trial who were screened annually for signs of ovarian cancer using transvaginal ultrasound and/or the CA-125 blood test.

  • Medicare Expands Coverage of Pet Scans as Cancer Diagnostic Tool
    CMS' Coverage with Evidence Development Project Shows PET Scans as "Reasonable and Necessary" for Initial Treatment Decisions of Most Solid Tumor Cancers
    read more
    (Apr. 6, 2009) - The Centers for Medicare & Medicaid Services (CMS) issued a final national coverage determination (NCD) to expand coverage for initial testing with positron emission tomography (PET) for Medicare beneficiaries who are diagnosed with and treated for most solid tumor cancers.

  • Yale Plans Closer Look at Exercise and Cancer
    Studies will chart recovery of active women with breast or ovarian disease
    read more
    HealthDay News  (Apr. 6, 2009) -- A Yale professor has received $7 million in federal grants for two studies into whether exercise affects ovarian and breast cancer recovery.

  • SNM Calls CMS PET Scan Decision a Major Benefit for Cancer Patients
    National Oncologic PET Registry Provided Overwhelming Evidence of PET's Value
    read more
    (Apr. 3, 2009) -SNM applauds today's decision by the Centers for Medicare and Medicaid Services (CMS) to expand coverage of positron emission tomography (PET) scans in the initial treatment strategy of patients with cancer. This decision was based, in large part, on compelling clinical evidence of the effectiveness of PET for cancer management and treatment contained in a comprehensive study known as the National Oncologic PET Registry (NOPR).

  • March 2009

  • Catching Ovarian Cancer Early May Miss Aggressive Tumors
    The finding casts the usefulness of screening into doubt, scientists say
    read more
    HealthDay News  (Mar. 24, 2009) -- Early-stage ovarian cancers may be slower growing and less likely to spread than the more aggressive forms typically found in advanced stages of the disease, researchers report.

  • Morphotek ®, Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
    read more
    PRNewswire (Mar. 23, 2009) - Morphotek ®, Inc., a subsidiary of Eisai Corporation of North America, announced today that the U.S. Food and Drug Administration (FDA) has agreed to and approved the design of a single, pivotal, Phase III clinical trial evaluating farletuzumab (also known as MORAb-003) in platinum-sensitive ovarian cancer patients experiencing their first relapse. The agreement was made under the Special Protocol Assessment (SPA) procedure.

  • Combo Screening Doesn't Spot Early Ovarian Cancer
    Even finding it early may not save lives, researchers say
    read more
    HealthDay News  (Mar. 20, 2009) -- A screening regimen that combines ultrasound and a blood test to detect CA125, a marker for ovarian cancer, fails to discover the cancer in its early stages and often results in unnecessary surgery, a new study shows.

Layout
Join our mailing list

Help patients and their caregivers know that they are not alone.